Allstate (NYSE: ALL) insider filing details CEO stock sales and options
Rhea-AI Filing Summary
The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open-market sales of Allstate common stock and related option movements. On December 15, 2025, he sold Allstate shares in several transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share under a Rule 10b5-1 trading plan adopted on June 27, 2025.
After these sales, he directly owned 128,005.491 Allstate shares, with additional indirect holdings through multiple GRATs, a 401(k) plan and trusts. The filing also lists employee stock options with exercise prices of $122.64, $137.10 and $159.17 per share, some of which were transferred on December 12, 2025 to TJW Options LLC series entities, while other option tranches remain directly held and vest in increments through 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,444 | $208.3456 | $301K |
| Sale | Common Stock | 3,810 | $209.3955 | $798K |
| Sale | Common Stock | 9,545 | $210.3659 | $2.01M |
| Sale | Common Stock | 2,008 | $210.9611 | $424K |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.725 to $208.690. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.825 to $209.780. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $209.835 to $210.8275. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.840 to $211.145. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Reflects transfer of 68,216 vested employee options to TJW Options LLC 2022 Series Last Third on December 12, 2025, formerly held directly by the reporting person. Stock option award granted on February 16, 2023 for 157,835 shares of common stock exercisable in three increments. The remaining increment will vest on February 16, 2026. Reflects transfer of 52,612 vested employee options to TJW Options LLC 2023 Series Middle Third on December 12, 2025, formerly held directly by the reporting person. 52,612 unvested employee options remain directly held. Stock option award granted on February 21, 2024, for 119,784 shares of common stock vesting in three equal increments. The remaining increments will vest on February 21, 2026 and February 21, 2027. Reflects transfer of 39,928 vested employee options to TJW Options LLC 2024 Series First Third on December 12, 2025, formerly held directly by the reporting person. 79,856 unvested employee options remain directly held.
FAQ
What insider stock transactions did Allstate (ALL) disclose in this filing?
The filing shows that chairman, president and CEO Thomas J. Wilson sold Allstate common stock on December 15, 2025 in four open-market transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share. The sales were reported as code S, indicating open-market or private sales.
Were the Allstate (ALL) CEO’s stock sales made under a Rule 10b5-1 trading plan?
Yes. The explanation notes that the sale transactions reported were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025. The filing also allows investors and SEC staff to request detailed information about the number of shares sold at each separate price within the reported price ranges.
What stock option holdings are reported for the Allstate (ALL) CEO?
The filing lists several employee stock options (rights to buy). These include options with an exercise price of $122.64 expiring on February 17, 2032, options with an exercise price of $137.10 expiring on February 16, 2033, and options with an exercise price of $159.17 expiring on February 21, 2034, each covering Allstate common stock in specified amounts. Some awards vest in increments, with remaining vesting dates on February 16, 2026, February 21, 2026 and February 21, 2027.
What transfers of stock options to LLCs are described for Allstate (ALL)’s CEO?
The explanations state that 68,216 vested employee options were transferred on December 12, 2025 to TJW Options LLC 2022 Series Last Third, 52,612 vested options were transferred to TJW Options LLC 2023 Series Middle Third and 39,928 vested options were transferred to TJW Options LLC 2024 Series First Third, all formerly held directly by the reporting person. Certain unvested options remain directly held.
